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ABSTRACT 
Albizia lebbeck (L.) BENTH (Fabaceae), popularly known as Sirisha, is employed in Indian folk medicine for the treatment of boils, cough, pain, 
swelling and it is also used against diarrhea. The anti-inflammatory activity was assessed using acute and subacute models of inflammation in 
rats. These studies demonstrated that oral administration of ethyl acetate extract of Albizia lebbeck (EAL) (100, 200, 400 mg/kg) exhibited 
significant anti-inflammatory activity. In acute inflammation as produced by carrageenan 62.19% after 5h, by histamine 43.19%, by dextran 
45.29%, by serotonin 68.84 while in subacute anti-inflammatory model using formaldehyde-induced hind paw edema (after 5 h) 31.5% and 
cotton pellets 13.48% protection from inflammation was observed at 400 mg/kg orally dose of EAL. EAL neither show ulcerogenic  effect at 
different doses of EAL nor show any sign of toxicity and mortality up to a dose level of 5000 mg/kg, p.o. in rats & mice. These data indicate that 
EAL possesses significant anti- anti-inflammatory activity. 
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INTRODUCTION 
The genus Albizia also called silk tree or silk plant, genus of 
trees or shrubs in the pea family (Fabaceae). The genus is 
pantropical, though most species are native to warm regions 
of the old world1. Albizia lebbeck is a deciduous Tree with an 
open, large, spreading crown; it usually reaches a height of 
15 - 20 meters, with exceptional specimens growing up to 30 
meters. In India plantation-grown siris yields a high quality 
hardwood that is traded in Europe as 'Indian walnut' or 
'koko'. Plants are used to provide shade for coffee and cocoa 
plantations as well as to provide a valuable timber and fuel. 
It is a popular amenity tree throughout the dry tropics 
because of its shady spreading habit, although the copious 
litter produced beneath it is often regarded as a 
disadvantage2-4. Albizia lebbeck was known as medicinal 
plant already in Ayurveda and it has been an important drug 
for centuries. Albizia lebbeck  has many medicinal properties 
like Antiseptic, antibacterial, anti-allergic, antidermatosis, 
antidysenteric etc. Used in the treatment of Bronchitis, piles, 
hemicranias, cough, tropical pulmonary eosinophilia, asthma 
etc. Albizia lebbeck is used as an astringent, to treat 
boils, cough, to treat the eye, flu, gingivitis, lung problems, 
pectoral problems, to treat abdominal tumors and it is also 
used as a tonic. The bark is used medicinally to 
treat inflammation5-7. Phytochemically the plant is less 
explored. Flavone, 3', 5-dihydroxy-4', 7-dimethoxyflavone 
and a nitrogenous compound, N-benzoyl-L-phenylalaninol, 
friedelan-3-one and g-sitosterol; Hexaglycosylated saponins, 
quercetin, unsaturated carboxylic acid methyl ester, a 
triterpene saponin, albigenic, albigenin, two tri-O glycoside 
flavonols i.e, kaempferol, quercetin; albizziahexoside (a 
hexaglycosylated saponins) and cardiac glycoside8-12. The 
biological activities which are attributed to this species are 
antibacterial, diuretic, analgesic & anti-inflammatory, anti-
tumor, in vitro antioxidant activity, antimicrobial, anti-
larvae, antiulcer, antiviral and ecbolic activities13-26. In the 
present study, Albizia lebbeck was selected because it is one 
of the medicinal plant commonly used in remedies to treat 
pain, swelling and fever in Indian traditional medicine and 
other countries in Asia. However, upto date no 
ethnopharmacological data have previously been 
systematically conducted to evaluate the anti-inflammatory 
action supporting traditional uses of this plant in folklore 
medicine. In this work we evaluate the anti-inflammatory 
potential of this whole plant (including aerial part and root) 
in experimental animals using ethyl acetate extract.  
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MATERIALS AND METHODS 
Chemicals 
Acetic acid, formalin, carrageenan, histamine, 5-
hydroxytryptamine (5-HT), prostaglandin E2 (PGE2), 
bradykinin, diclofenac and phenylbutazone (PBZ) were 
procured from Sigma Chemicals, St. Louis, MO, USA. 
Formaldehyde was purchased from Hi-Media Laboratories, 
Mumbai, India, and the water represents the double distilled 
water. 
Plant material 
Whole plant of Albizia lebbeck was collected from the Dausa, 
Rajasthan and after due identification with the help of floras 
and previous works deposited at Botanical Survey of India, 
Jodhpur, India herbarium vide voucher specimen number 
BSI/JODHPUR/AL/1. 
Preparation of extract 
Two hundred gram of the air dried and coarsely ground 
plant material was defatted with petroleum ether (60-80°c) 
by soxhlation for three days and then the solvent free marc 
was extracted with the ethyl acetate by soxhlation for 4 days 
and extract was concentrated in-vacuo in a rotary 
evaporator. The dried marc was extracted with distilled 
water by maceration in a round bottom flask for 24 h. After 
24 h it was filtered though muslin cloth followed by buchner 
funnel. Maceration process was repeated using marc for 
another two times and all the three filterates were collected 
and combined. The solvent was removed by in-vacuo in 
rotary evaporator. The dried extracts were placed in a 
desiccator and used for further studies.  
Animals 
Thirty animals made up of equal number of male and female 
rats were used for this study in a complete randomized 
design. Animals were randomly divided into five groups with 
six animals per group and were orally administered as the 
following: Group 1, control was orally administered, once 
daily with 1mL of distilled water (vehicle); Groups II, III, IV, 
were treated with 100, 200 and 400mg/kg body weight of 
the ethyl acetate extract of Albizia lebbeck, respectively, and 
Group V received diclofenac (10 mg/kg body weight) 
reference drug, which served as a positive control. Oral 
administration was carried out using a metal oropharyngeal 
cannula. The experiments on animals were conducted in 
accordance with the internationally accepted principles for 
laboratory animal use and the experimental protocols duly 
approved by the Institutional Ethical Committee.  
Acute toxicity study 
The acute toxicity test of the ethyl acetate fraction of Albizia 
lebbeck was done by up and down method [in accordance 
with the Organization for Economic Cooperation and 
Development (OECD) guidelines, 2001]. Overnight fasted 
albino rats were used for study (three animals in group). The 
fraction was administered to all the three animals in a group 
at a starting single dose of 5 mg/kg. Animals were observed 
for a period of 2 hours, then occasionally for 4 hours for 
severity of any toxic signs and mortality. When no mortality 
was observed the same dose would be additionally 
administered to one more animal. If no mortality is observed 
at this dose, the same procedure would be repeated for dose 
levels of 50, 300, 2000 and 5000 mg/kg of fraction on 
separate newer groups. The behavioral changes closely 
observed for were: hyperactivity, ataxia, tremors, 
convulsions, salivation, diarrhea, lethargy, sleep and coma. 
The animals were kept under observation up to 14 days 
after drug administration to find out any delayed 
mortality27.  
Anti-inflammatory activity 
A. Carrageenan induced rat paw edema 
Carrageenan induced rat paw edema was done by the 
method of28. Inflammation was induced by injection of 0.1 
ml of freshly prepared carrageenan (1%) aqueous 
suspension in normal saline underneath the plantar tissue of 
the right hind paw of rats. The different groups of rats were 
administered with EAL (100, 200 and 400 mg/kg, p.o.) and 
diclofenac (10 mg/kg, p.o.). The control group received 
vehicle (distilled water, 10 ml/kg, p.o.). 1 h after drug 
treatment, paw edema was induced by the injection of 
carrageenan (an edematogenic agent). The paw volume was 
measured by a Plethysmometer. The measures were 
determined at 0 h (Vo: before edematogenic agent injection) 
and 1,2,3,4 and 5h intervals later (Vt). The difference 
between Vt and Vo was taken as the edema value. The 
percentage of inhibition was calculated according to the 
following formula: 
% inhibition = (Vt − Vo)control − (Vt − Vo)treated X 100  
                                     (Vt − Vo) control 
B. Histamine induced rat paw edema 
Inflammation was induced by injection of 0.1 ml of freshly 
prepared histamine (1%) aqueous suspension in normal 
saline underneath the plantar tissue of the right hind paw of 
rats29. The drug treatment and paw volume was measured in 
a similar manner to that of carrageenan induced paw edema 
model. 
C. Dextran induced rat paw edema 
Inflammation was induced by injection of 0.1 ml of freshly 
prepared dextran (1%) aqueous suspension in normal saline 
underneath the plantar tissue of the right hind paw of rats30. 
The drug treatment and paw volume was measured in a 
similar manner to that of carrageenan induced paw edema 
model. 
D. Serotonin induced rat paw edema 
Inflammation was induced by injection of 0.1 ml of freshly 
prepared Serotonin (1%) aqueous suspension in normal 
saline underneath the plantar tissue of the right hind paw of 
rats31-32. The drug treatment and paw volume was measured 
in a similar manner to that of carrageenan induced paw 
edema model. 
E. Formaldehyde induced rat paw edema 
Inflammation was induced by injection of 0.1 ml of freshly 
prepared Formaldehyde (3%) underneath the plantar tissue 
of the right hind paw of rats33. The test drug was 
administered consecutively for seven days to all the groups. 
On seventh day, after 1 h of drug administration, paw edema 
of the rat was induced by subplantar injection of 
formaldehyde solution. The paw volume was determined at 
0 h and at 3, 24 and 48 h after formaldehyde injection as 
described in carrageenan model. 
F. Cotton pellet induced granuloma in rats 
The effect of Group III: Ethyl acetate extract of Albizia 
lebbeck on the chronic phases of inflammation was assessed 
in the cotton pellet induced granuloma rat model34. 
Autoclaved cotton pellets weighing 100 mg each were 
implanted subcutaneously. One on each side of the abdomen 
of the animal, through a small ventral incision of rats 
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anesthetized with ether. The different groups of rats were 
administered with EAL (100, 200 and 400 mg/kg, p.o.) and 
diclofenac (10 mg/kg. p.o.) once daily for 7 consecutive days 
from the day of cotton pellet insertion. The control group 
received vehicle (distilled water, 10 ml/kg, p.o.). On the 
eighth day the animals were sacrificed and the cotton pellets 
were removed, dried at 60°C for 24 h and their mass was 
determined. The results are expressed as mg granulation 
tissue formed per 100 g body weight. 
G. Statistical analyses 
The data were expressed as mean ± S.E.M. Results were 
analyzed statistically by one-way analyses of variance 
(ANOVA) followed by Tukey’s test using the Origin version 
6.0 (Microcal, Northampton, MA, USA) for Window software. 
P-value <0.05 was regarded as statistically significant. 
RESULTS AND DISCUSSION 
A. Carrageenan induced rat paw edema 
The results of anti-inflammatory activity of ethyl acetate 
fraction of Albizia lebbeck on carrageenan induced paw 
edema is shown in Table 1 The lower dose i.e. EAL-100 
showed inhibition at both early and late phase; though 
maximum inhibition was at late phase (67.65%, P < 0.01). 
The higher dose i.e. EAL-400 also showed maximum anti-
inflammatory activity at late phase (39.87%) but this activity 
was less than that of EAL-200 (58.9%) at both early and late 
phase. The standard Diclofenac-10 showed maximum 
activity at early phase (55.98%, P<0.01). In this model, the 
lower dose showed more inhibition of edema formation than 
standard diclofenac. 
 
Table 1: Anti-inflammatory activity of ethyl acetate fraction of Albizia lebbeck in carrageenan induced rat paw edema. 
  % Increase in paw volume 
Treatment 
group 
After 1 h After 2 h After 3 h After 4 h After 5 h 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Control 
15.89 ± 
2.24 
  
24.56 ± 
4.56 
  
32.34 ± 
2.38 
  
30.13 ± 
2.54 
  
29.58 ± 
2.36 
  
EAL-100 
5.45 ± 
1.42 
53.54 
7.09 ± 
1.67 
54.65 
12.14 ± 
1.78 
48.89 
11.33 ± 
1.76 
60.09 
8.13 ± 
2.65 
67.65 
EAL-200 
7.43 ± 
.108* 
45.65 
10.06 ± 
1.24** 
46.09 
14.46 ± 
2.14** 
52.43 
14.87 ± 
1.16** 
53.76 
13.40 ± 
2.12 
58.9 
EAL-400 
10.32 ± 
1.46 
37.87 
18.03 ± 
2.36 
29.65 
22.23 ± 
2.14 
28.56 
22.46 ± 
3.53 
28.9 
16.26 ± 
3.16 
39.87 
Diclofenac-
10 
8.98 ± 
2.08 
43.45 
13.45 ± 
1.78* 
48.78 
12.76 ± 
4.88** 
55.98 
16.76 ± 
2.67* 
43.23 
15.01 ± 
2.39* 
44.43 
Value are expressed as mean ± SEM, (n=6). *P<0.05; **P<0.01. 
B. Histamine induced rat paw edema 
The results of anti-inflammatory activity of ethyl acetate 
fraction of Albizia lebbeck on histamine induced paw edema 
is shown in Table 2. In this model, the ethyl acetate fraction 
of Albizia lebbeck at both dose levels and standard diclofenac 
showed anti-inflammatory activity at late phase. A clear dose 
dependent inhibition of paw edema was observed. The 
percentage inhibition of EAL-100 was 33.37% (P<0.05), 
EAL-200 was 38.82% (P<0.01 while that of EAL-400 was 
43.19% (P<0.01). The later was nearer to standard 
Diclofenac-10 (55.89%, P<0.01). 
 
Table 2: Anti-inflammatory activity of ethyl acetate fraction of Albizia lebbeck in histamine induced rat paw edema. 
  % Increase in paw volume 
Treatment 
group 
After 1 h After 2 h After 3 h After 4 h After 5 h 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Control 
41.12 ± 
1.82 
  
45.67 ± 
3.81 
  
44.56 ± 
2.90 
  
42.18 ± 
4.56 
  
39.23 ± 
1.79 
  
EAL-100 
38.71 ± 
2.59 
5.25 
38.43 ± 
1.62 
21.42 
33.51 ± 
1.32* 
30.40 
30.32 ± 
1.30 
32.40 
28.47 ± 
2.56** 
33.37 
EAL-200 
40.18 ± 
1.57* 
7.49 
35.61 ± 
2.60* 
25.22 
29.17 ± 
1.72* 
33.18 
27.40 ± 
2.52* 
35.38 
24.32 ± 
1.73** 
38.82 
EAL-400 
36.25 ± 
1.35 
13.18 
32.86 ± 
1.81* 
29.40 
28.40 ± 
2.10* 
38.23 
25.33 ± 
3.14* 
40.15 
22.17 ± 
1.54** 
43.19 
Diclofenac-
10 
29.28 ± 
2.12* 
28.10 
27.12 ± 
2.16** 
39.89 
28.60 ± 
3.80** 
41.16 
22.15 ± 
2.53** 
52.12 
20.18 ± 
2.34** 
55.89 
Value are expressed as mean ± SEM, (n=6). *P<0.05; **P<0.01. 
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C. Dextran induced rat paw edema 
The results of anti-inflammatory activity of ethyl acetate 
fraction of Albizia lebbeck on dextran induced paw edema is 
shown in Table 3. In this model, a clear dose dependent 
inhibition of paw edema was observed at both early and late 
phases. The higher dose showed distinctly more inhibition 
than lower dose at both phases (P<0.05). The anti-
inflammatory activity of higher dose was more at later phase 
(50%) than early phase. The standard diclofenac showed 
poor anti-inflammatory activity in this model. 
 
Table 3: Anti-inflammatory activity of ethyl acetate fraction of Albizia lebbeck in dextran induced rat paw edema. 
  % Increase in paw volume 
Treatment 
group 
After 1 h After 2 h After 3 h After 4 h After 5 h 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Control 
41.33 ± 
3.18 
  
44.74 ± 
4.64 
  
39.43 ± 
2.69 
  
32.41 ± 
4.43 
  
24.37 ± 
1.38 
  
EAL-100 
30.19 ± 
2.14 
28.18 
32.18 ± 
2.52 
25.46 
26.32 ± 
1.32 
29.13 
20.48 ± 
2.18 
33.40 
17.18 ± 
1.36 
17.61 
EAL-200 
24.15 ± 
1.56 
22.74 
26.73 ± 
2.63 
27.48 
24.13 ± 
2.44 
32.27 
15.43 ± 
3.48 
40.18 
12.37 ± 
3.69 
32.16 
EAL-400 
29.14 ± 
1.27* 
34.37 
31.47 ± 
3.18* 
36.18 
30.38 ± 
3.67* 
38.47 
19.79 ± 
2.67** 
48.37 
16.82 ± 
4.31* 
45.29 
Diclofenac-
10 
39.17 ± 
3.17 
6.84 
41.04 ± 
4.37 
13.46 
37.42 ± 
1.30 
12.43 
27.40 ± 
3.81 
20.32 
24.61 ± 
3.62 
09.33 
Value are expressed as mean ± SEM, (n=6). *P<0.05; **P<0.01. 
 
D. Serotonin induced rat paw edema 
The results of anti-inflammatory activity of ethyl acetate 
fraction of Albizia lebbeck on serotonin induced paw edema 
is shown in Table 4. The maximum paw thickness was 
observed at 3rd h after sub-planter injection in all groups. 
The animals treated with lower and higher doses of EAL 
(100, 200 and 400 mg/kg) produced statistically significant 
inhibition at 1st h (P<0.05; P<0.01 & P<0.01, respectively), 
2nd and 3rd h (P<0.05) and at 5th h (P < 0.01). Standard drug 
diclofenac-10 showed significant decrease in paw volume at 
1st, 2nd h (P<0.05) and at 3rd, 4th and 5th h (P<0.01). The 
maximum decrease of paw volume in both the doses of EAL 
and diclofenac treated groups was found at 5th h (F<0.001). 
The percent inhibition of EAL-400 group at 5th h was same as 
that of standard group. The extract effectively suppressed 
the inflammation produced by serotonin. 
 
Table 4: Anti-inflammatory activity of ethyl acetate fraction of Albizia lebbeck in serotonin induced rat paw edema. 
  % Increase in paw volume 
Treatment 
group 
After 1 h After 2 h After 3 h After 4 h After 5 h 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Vol. 
Increase 
% 
Change 
Control 
15.32 ± 
1.62 
  
20.46 ± 
2.15 
  
33.46 ± 
2.64 
  
28.34 ± 
1.28 
  
23.46 ± 
2.62 
  
EAL-100 
8.14 ± 
2.15 
44.37 
12.40 ± 
3.36 
38.46 
16.13 ± 
1.48 
43.10 
15.27 ± 
1.54 
41.07 
6.43 ± 
1.02 
68.84 
EAL-200 
5.32 ± 
1.62* 
49.40 
13.17 ± 
1.02 
34.31 
18.14 ± 
2.46* 
46.32 
14.32 ± 
1.63** 
47.40 
7.38 ± 
1.86** 
54.32 
EAL-400 
6.18 ± 
2.35** 
57.18 
15.40 ± 
2.48 
40.11 
19.40 ± 
1.37* 
48.13 
13.65 ± 
2.65* 
49.47 
5.14 ± 
0.89** 
58.40 
Diclofenac-
10 
7.07 ± 
3.44* 
61.08 
10.86 ± 
3.18* 
64.16 
13.45 ± 
2.43** 
67.32 
8.47 ± 
3.67** 
72.46 
5.23 ± 
1.36** 
75.43 
Value are expressed as mean ± SEM, (n=6). *P<0.05; **P<0.01. 
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E. Formaldehyde induced rat paw edema 
The results of anti-inflammatory activity of ethyl acetate 
fraction of Albizia lebbeck in formaldehyde induced paw 
edema is shown in Table 5. Injection of formaldehyde 
subcutaneously into hind paw of rats produces localized 
inflammation. The administration of EAL-100, EAL-200 & 
EAL-400 and diclofenac-10 daily for 7 days successfully 
significantly (F<0.001) inhibited edema induced by 
formaldehyde. EAL-100, EAL-200 and EAL-400 group 
showed maximum decrease in paw volume at 3 h (P<0.05, 
P<0.001 and P<0.01 respectively). Diclofenac-10 group 
showed decrease in paw volume at 3 h (44.37%, P<0.001) 
and the decreased in paw volume at 48 h was almost same 
(45.87%, P<0.01). 
 
Table 5: Anti-inflammatory activity of ethyl acetate fraction of Albizia lebbeck in formaldehyde induced rat paw edema. 
  % Increase in paw volume 
Treatment 
group 
After 3 h After 24 h After 48 h 
Vol. Increase 
% 
Change 
Vol. Increase 
% 
Change 
Vol. Increase 
% 
Change 
Control 52.16 ± 2.69   56.14 ± 2.46   42.18 ± 4.84   
EAL-100 38.4 ± 2.16 33.14 41.14 ± 3.78 32.47 35.67 ± 2.46 23.4 
EAL-200 33.16 ± 1.45* 35.36 36.18 ± 2.14** 34.48 32.40 ± 1.49 27.6 
EAL-400 31.42 ± 2.64** 40.42 35.40 ± 3.67* 37.63 29.47 ±2.69* 31.54 
Diclofenac-10 28.40 ± 1.20*** 44.37 32.42 ± 2.47** 41.68 21.26 ± 4.95** 45.87 
Value are expressed as mean ± SEM, (n=6). *P<0.05; **P<0.01, ***P<0.001  
 
F. Cotton pellet induced granuloma in rats 
The results of anti-inflammatory activity of ethyl acetate 
fraction of Albizia lebbeck in cotton pellet induced 
granuloma is shown in Table 6. EAL-100, EAL-200 and EAL-
400 groups showed 1.46%, 1.32% and 13.48% decrease in 
granuloma formation respectively as compared to control 
group, while standard diclofenac-10 group showed 
significant decrease in granuloma formation (33.04%, 
P<0.001).
 
Table 6: Anti-inflammatory activity of ethyl acetate fraction of Albizia lebbeck in cotton pellet induced granuloma in rats. 
Treatment group 
Pellet weight (g / 100 g 
b.w.) 
% Change 
Control 0.112 ± 0.002   
EAL-100 0.109 ± 0.005 1.46 
EAL-200 0.106 ± 0.004 1.32 
EAL-400 0.98 ± 0.005 13.48 
Diclofenac-10 0.72 ± 0.005*** 33.4 
Value are expressed as mean ± SEM, (n=6). ***P<0.001 
 
CONCLUSION  
In conclusion, the present study clearly showed that ethyl 
acetate extract of whole plant (including aerial part and 
root) of Albizia lebbeck possessed good anti-inflammatory 
activity and also scientifically validated the traditional use of 
this plant for treating inflammatory disorders in the folk 
medicine. The advantages of this extract, viz., better and 
safer anti-inflammatory profile deserves further studies to 
identify the possible mechanism of action as well as 
establishing the therapeutic value in the treatment of 
inflammatory diseases. 
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